本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tiziana Life Sciences PLC

1.57
+0.09006.08%
盤後1.620.0500+3.18%18:46 EDT
成交量:37.72萬
成交額:58.92萬
市值:1.63億
市盈率:-11.77
高:1.60
開:1.56
低:1.50
收:1.48
資料載入中...
2024/05/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/06/14

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/04/26

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/01

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/20

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/05/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/14

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]